Drug Type Small molecule drug  | 
Synonyms Sparfloxacin Lactate, Zagam, 乳酸司帕沙星 + [18]  | 
Action inhibitors  | 
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseApproved  | 
First Approval Date United States (19 Dec 1996),   | 
Regulation-  | 
Molecular FormulaC19H22F2N4O3  | 
InChIKeyDZZWHBIBMUVIIW-DTORHVGOSA-N  | 
CAS Registry110871-86-8  | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | Sparfloxacin | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Anaerobic bacterial infection | China   | 20 Nov 1999 | |
| Chlamydia Infections | China   | 20 Nov 1999 | |
| Legionellosis | China   | 20 Nov 1999 | |
| Mycoplasma Infections | China   | 20 Nov 1999 | |
| Bacterial Infections | United States   | 19 Dec 1996 | 





